Eurofins Scientific Valuation
| ERFSF Stock | USD 59.96 0.27 0.45% |
At this time, the firm appears to be overvalued. Eurofins Scientific shows a prevailing Real Value of $51.48 per share. The current price of the firm is $59.96. Our model computes the value of Eurofins Scientific from reviewing the firm fundamentals such as Shares Outstanding of 192.56 M, profit margin of 0.1 %, and Current Valuation of 15.96 B as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
Please note that Eurofins Scientific's price fluctuation is very steady at this time. Calculation of the real value of Eurofins Scientific is based on 3 months time horizon. Increasing Eurofins Scientific's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Eurofins Scientific SE is useful when determining the fair value of the Eurofins pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Eurofins Scientific. Since Eurofins Scientific is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Eurofins Pink Sheet. However, Eurofins Scientific's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 59.96 | Real 51.48 | Hype 59.96 | Naive 60.22 |
The real value of Eurofins Pink Sheet, also known as its intrinsic value, is the underlying worth of Eurofins Scientific Company, which is reflected in its stock price. It is based on Eurofins Scientific's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Eurofins Scientific's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Eurofins Scientific's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Eurofins Scientific SE helps investors to forecast how Eurofins pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Eurofins Scientific more accurately as focusing exclusively on Eurofins Scientific's fundamentals will not take into account other important factors: Eurofins Scientific Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Eurofins Scientific's current stock value. Our valuation model uses many indicators to compare Eurofins Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eurofins Scientific competition to find correlations between indicators driving Eurofins Scientific's intrinsic value. More Info.Eurofins Scientific SE is one of the top stocks in price to earning category among related companies. It is one of the top stocks in price to book category among related companies fabricating about 0.13 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Eurofins Scientific SE is roughly 7.94 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Eurofins Scientific by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Eurofins Scientific's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eurofins Scientific's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Eurofins Scientific's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Eurofins Scientific and how it compares across the competition.
About Eurofins Scientific Valuation
The pink sheet valuation mechanism determines the current worth of Eurofins Scientific SE on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Eurofins Scientific SE. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Eurofins Scientific based exclusively on its fundamental and basic technical indicators. By analyzing Eurofins Scientific's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Eurofins Scientific's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eurofins Scientific. We calculate exposure to Eurofins Scientific's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Eurofins Scientific's related companies.Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. Eurofins Scientific operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 61000 people.
8 Steps to conduct Eurofins Scientific's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Eurofins Scientific's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Eurofins Scientific's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Eurofins Scientific's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Eurofins Scientific's revenue streams: Identify Eurofins Scientific's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Eurofins Scientific's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Eurofins Scientific's growth potential: Evaluate Eurofins Scientific's management, business model, and growth potential.
- Determine Eurofins Scientific's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Eurofins Scientific's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of Eurofins Scientific represents a small ownership stake in the entity. As a stockholder of Eurofins, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Eurofins Scientific Dividends Analysis For Valuation
Please note that Eurofins Scientific has scaled down on payment of dividends at this time.
There are various types of dividends Eurofins Scientific can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Eurofins shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Eurofins Scientific SE directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Eurofins pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Eurofins Scientific by the value of the dividends paid out.
Eurofins Scientific Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Eurofins Scientific does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 192.3 M | |
| Quarterly Earnings Growth Y O Y | -0.265 | |
| Forward Price Earnings | 17.1527 | |
| Retained Earnings | 2 B |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eurofins Scientific SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Eurofins Pink Sheet analysis
When running Eurofins Scientific's price analysis, check to measure Eurofins Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurofins Scientific is operating at the current time. Most of Eurofins Scientific's value examination focuses on studying past and present price action to predict the probability of Eurofins Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurofins Scientific's price. Additionally, you may evaluate how the addition of Eurofins Scientific to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |